Acetaminophen ASD-ADHD

The Acetaminophen ASD/ADHD Litigation Group assists members investigating and litigating cases where children developed autism spectrum disorder (ASD) and/or attention-deficit/hyperactivity disorder (ADHD) because of a mother’s prenatal use of acetaminophen. Manufacturers of acetaminophen have failed to include any warning to pregnant women about these risks and have marketed acetaminophen as safe for pregnant women, despite the growing connection between prenatal exposure to acetaminophen and neurodevelopmental injuries in children. Members collaborate and strategize on how to best litigate these cases and recover for injured clients.

Group History

The Acetaminophen ASD/ADHD Litigation Group was formed at the 2023 Winter Convention. Members have access to a document library and list server. The Group meets at AAJ Annual and Winter conventions and plans to host programs and meetings throughout the year.

Dues: The Litigation Group is complementary to members of the AAJ Pharmaceutical and Medical Device Section who can agree to the terms and conditions of membership in the Litigation Group's Affidavit. If you are not yet a member, you can join the Pharmaceutical and Medical Device Section here.

Chair

Ashley Barriere | Keller Postman LLC, New Orleans, LA
W. Roger Smith III | Beasley, Allen, Crow, Methvin, Portis & Miles, PC, Montgomery, AL